Deerfield Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-255,456
Closed -$4.37M 166
2021
Q2
$4.37M Hold
255,456
0.08% 130
2021
Q1
$5.33M Hold
255,456
0.11% 119
2020
Q4
$5.85M Sell
255,456
-1,318,078
-84% -$25.1M 0.12% 117
2020
Q3
$25.7M Sell
1,573,534
-1,003,345
-39% -$18.2M 0.62% 54
2020
Q2
$34.9M Sell
2,576,879
-181,388
-7% -$2.11M 1.02% 31
2020
Q1
$32.7M Sell
2,758,267
-38,766
-1% -$859K 1.04% 31
2019
Q4
$69.6M Sell
2,797,033
-311,971
-10% -$6.32M 2.22% 14
2019
Q3
$52.9M Hold
3,109,004
2.16% 10
2019
Q2
$70.8M Buy
3,109,004
+1,103,040
+55% +$29.7M 2.54% 8
2019
Q1
$64.5M Sell
2,005,964
-72,411
-3% -$2.24M 2.47% 10
2018
Q4
$58.6M Sell
2,078,375
-69,575
-3% -$2.04M 2.34% 10
2018
Q3
$61.8M Buy
2,147,950
+1,127,950
+111% +$33.9M 2.21% 13
2018
Q2
$38.2M Buy
1,020,000
+187,500
+23% +$7.36M 1.34% 24
2018
Q1
$32.7M Sell
832,500
-635,841
-43% -$23.2M 1.13% 27
2017
Q4
$47.6M Buy
1,468,341
+258,341
+21% +$7.75M 1.87% 17
2017
Q3
$37.7M Buy
1,210,000
+20,423
+2% +$604K 1.7% 19
2017
Q2
$33.2M Buy
+1,189,577
New +$26.9M 1.77% 18

Other funds holding XENT

Deerfield Management's XENT Position: Q3 2021 in Review

Deerfield Management sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 255,456 shares — an estimated $4.37M sold.

Deerfield Management first reported a position in XENT in Q2 2017 and held it in 17 quarters. The position peaked at $70.8M in Q2 2019. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Deerfield Management reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Deerfield Management sold 255,456 Intersect ENT, Inc shares in Q3 2021, an estimated $4.37M.
  • Deerfield Management first reported a position in Intersect ENT, Inc in Q2 2017 and held it in 17 quarters.
  • Deerfield Management's Intersect ENT, Inc position peaked at $70.8M in Q2 2019.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Deerfield Management's 13F filing for Q3 2021, filed 15 Nov 2021.